Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma (Q64096454)

From Wikidata

Jump to navigation Jump to search

No description defined

edit

Language	Label	Description	Also known as
English	Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma	No description defined

Statements

instance of

scholarly article

0 references

title

Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma (English)

0 references

main subject

Brain metastases

0 references

Tyrosine Kinase Inhibitors

0 references

whole brain radiotherapy

0 references

brain metastasis

1 reference

based on heuristic

inferred from title

adenocarcinoma

1 reference

based on heuristic

inferred from title

author name string

Changhui Li

series ordinal

1

0 references

Jindong Guo

series ordinal

2

0 references

Lei Zhao

series ordinal

3

0 references

Fang Hu

series ordinal

4

0 references

Wei Nie

series ordinal

5

0 references

Huimin Wang

series ordinal

6

0 references

Xiaoxuan Zheng

series ordinal

7

0 references

Yinchen Shen

series ordinal

8

0 references

Ping Gu

series ordinal

9

0 references

Yujun Zhang

series ordinal

10

0 references

Xueyan Zhang

series ordinal

11

0 references

language of work or name

English

0 references

publication date

2019

0 references

published in

Cancer Management and Research

0 references

volume

11

0 references

page(s)

3433-3443

0 references

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

start time

1 April 2019

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Quantitative Study of Blood.Brain Barrier Permeability Changes after Experimental Whole-Brain Radiation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of radiation on the blood-brain barrier and optimum time of chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain metastases. Histology, multiplicity, surgery, and survival

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of brain irradiation on blood-CSF barrier permeability of chemotherapeutic agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of gefitinib (ZD1839) on metastatic brain tumour.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Whole-brain radiotherapy in the management of brain metastasis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of the blood-brain barrier in the formation of brain metastases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic and pharmacodynamic study of Gefitinib in a mouse model of non-small-cell lung carcinoma with brain metastasis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR mutation and brain metastasis in pulmonary adenocarcinomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of central nerve system metastases from non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

U.S. Food and Drug Administration approval summary: Erlotinib for the first-line treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta-analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferio

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

First-line epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor alone or with whole-brain radiotherapy for brain metastases in patients with EGFR-mutated lung adenocarcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer Statistics, 2017.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-Effectiveness of Osimertinib for EGFR Mutation-Positive Non-Small Cell Lung Cancer after Progression following First-Line EGFR TKI Therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracranial control and survival outcome of tyrosine kinase inhibitor (TKI) alone versus TKI plus radiotherapy for brain metastasis of epidermal growth factor receptor-mutant non-small cell lung cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31114377

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2147/CMAR.S196881

0 references

PMC publication ID

6497873

0 references

PubMed publication ID

31114377

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64096454&oldid=1886411284"